It comes after yesterday's announcement by Axa PPP that it had removed all cost and time limits for licensed cancer drug treatment for patients on standard individual and SME plans.
This was in response to Aviva's move in October to cover cancer treatments recommended by specialists in full and also extend coverage to include non-NHS drugs one related treatments and scans and rehabilitation.
The Association of Medical Insurance Intermediaries (AMII) gave its approval to both moves, calling Axa PPP's review of its heart disease and cancer coverage ‘positive', following on from Aviva's improvement.
Andrew Tripp, chairman of AMII, said: "We are delighted to see that insurers are working hard to improve the cover for our clients.
"As specialist independent intermediaries, this gives our members more choice to offer customers which has to be good news for the consumer."
Advertisment
Stay up to date with all the latest news, product development and changes happening within the protection and health insurance market.
All of the latest news and features on all aspects of the protection and health insurance market are available from our print edition.
Advertisment
Visitor Comment
Add your comment
Add your comment